SMT201600083B - Nuove forme e sali di un inibitore di diidropirrolo[1,2-c]imidazolil aldosterone sintasi o aromatasi - Google Patents

Nuove forme e sali di un inibitore di diidropirrolo[1,2-c]imidazolil aldosterone sintasi o aromatasi

Info

Publication number
SMT201600083B
SMT201600083B SM201600083T SM201600083T SMT201600083B SM T201600083 B SMT201600083 B SM T201600083B SM 201600083 T SM201600083 T SM 201600083T SM 201600083 T SM201600083 T SM 201600083T SM T201600083 B SMT201600083 B SM T201600083B
Authority
SM
San Marino
Prior art keywords
synthasis
diidropirrol
aromatasis
aldosterone
imidazolyl
Prior art date
Application number
SM201600083T
Other languages
English (en)
Italian (it)
Inventor
Paul Sutton
Eric Loeser
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47604250&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201600083(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SMT201600083B publication Critical patent/SMT201600083B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SM201600083T 2012-01-17 2016-03-23 Nuove forme e sali di un inibitore di diidropirrolo[1,2-c]imidazolil aldosterone sintasi o aromatasi SMT201600083B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261587280P 2012-01-17 2012-01-17
PCT/US2013/021521 WO2013109514A1 (en) 2012-01-17 2013-01-15 New forms and salts of a dihydropyrrolo[1,2-c]imidazolyl aldosterone synthase or aromatase inhibitor

Publications (1)

Publication Number Publication Date
SMT201600083B true SMT201600083B (it) 2016-04-29

Family

ID=47604250

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201600083T SMT201600083B (it) 2012-01-17 2016-03-23 Nuove forme e sali di un inibitore di diidropirrolo[1,2-c]imidazolil aldosterone sintasi o aromatasi

Country Status (40)

Country Link
US (2) US9334276B2 (pl)
EP (1) EP2804863B1 (pl)
JP (1) JP5749410B2 (pl)
KR (2) KR20140093726A (pl)
CN (1) CN104039793B (pl)
AP (1) AP2014007762A0 (pl)
AR (1) AR089728A1 (pl)
AU (1) AU2013209952B2 (pl)
BR (1) BR112014017260A8 (pl)
CA (1) CA2863339C (pl)
CL (1) CL2014001863A1 (pl)
CO (1) CO7000775A2 (pl)
CR (1) CR20140345A (pl)
CU (1) CU20140086A7 (pl)
CY (1) CY1117914T1 (pl)
DK (1) DK2804863T3 (pl)
EA (1) EA026232B1 (pl)
ES (1) ES2564143T3 (pl)
GT (1) GT201400155A (pl)
HR (1) HRP20160178T1 (pl)
HU (1) HUE026984T2 (pl)
IL (1) IL233541B (pl)
IN (1) IN2014DN06781A (pl)
JO (1) JO3137B1 (pl)
MA (1) MA35858B1 (pl)
MX (1) MX2014008686A (pl)
NZ (1) NZ626277A (pl)
PE (1) PE20142358A1 (pl)
PH (1) PH12014501638A1 (pl)
PL (1) PL2804863T3 (pl)
RS (1) RS54589B1 (pl)
SG (1) SG11201404061YA (pl)
SI (1) SI2804863T1 (pl)
SM (1) SMT201600083B (pl)
TN (1) TN2014000256A1 (pl)
TW (1) TWI609869B (pl)
UA (1) UA114803C2 (pl)
UY (1) UY34576A (pl)
WO (1) WO2013109514A1 (pl)
ZA (1) ZA201404314B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA33904B1 (fr) * 2010-01-14 2013-01-02 Novartis Ag Utilisation d'un agent de modification d'hormones surrénaliennes
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
TWI707682B (zh) 2014-07-07 2020-10-21 瑞士商瑞科戴迪股份有限公司 醫藥劑型
AU2016210899B2 (en) 2015-01-29 2019-03-07 Recordati Ag Process for the production of condensed imidazolo Derivatives
WO2016164476A2 (en) * 2015-04-06 2016-10-13 Millendo Therapeutics, Inc. Combination therapy for treating disorders associated with excess cortisol production
JP7130636B2 (ja) * 2016-10-27 2022-09-05 ダミアン ファーマ アーゲー アルドステロンシンターゼ阻害剤
WO2018078049A1 (en) * 2016-10-27 2018-05-03 Damian Pharma Ag Aldosterone synthase inhibitor
SG11202010906XA (en) 2018-05-03 2020-12-30 Damian Pharma Ag R-fadrozole for use in the treatment of aldostonerism

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1315449A (en) * 1918-11-15 1919-09-09 Frank B Yingling Shaper-feed.
US4617307A (en) * 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US5066656A (en) 1989-11-01 1991-11-19 Janssen Pharmaceutica N.V. Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
MTP1076B (en) 1990-01-12 1991-09-30 Ciba Geigy Ag Hemihydrate
JPH07503242A (ja) 1992-01-27 1995-04-06 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ アロマターゼ阻害剤としてのピロロイミダゾリルおよびイミダゾピリジニル置換1h−ベンズイミダゾール誘導体
PT1565463E (pt) * 2002-11-18 2008-09-10 Novartis Ag Derivados de imidazo[1,5-a]piridina e métodos para tratar doenças mediadas pela aldosterona
GT200600381A (es) * 2005-08-25 2007-03-28 Compuestos organicos
MX2009006481A (es) 2006-12-18 2009-06-26 Novartis Ag Derivados de imidazol 1-sustituidos, y su uso como inhibidores de la sintasa de aldosterona.
CN102666535B (zh) 2009-11-30 2015-02-25 诺华股份有限公司 作为醛固酮合酶抑制剂的咪唑衍生物
MA33904B1 (fr) * 2010-01-14 2013-01-02 Novartis Ag Utilisation d'un agent de modification d'hormones surrénaliennes

Also Published As

Publication number Publication date
AU2013209952B2 (en) 2016-09-01
PH12014501638B1 (en) 2014-10-13
EA201491374A1 (ru) 2014-12-30
CL2014001863A1 (es) 2014-11-07
CY1117914T1 (el) 2017-05-17
IL233541A0 (en) 2014-08-31
CU20140086A7 (es) 2014-12-26
RS54589B1 (sr) 2016-08-31
UA114803C2 (uk) 2017-08-10
US20140364470A1 (en) 2014-12-11
ES2564143T3 (es) 2016-03-18
WO2013109514A1 (en) 2013-07-25
CN104039793A (zh) 2014-09-10
CN104039793B (zh) 2017-05-10
NZ626277A (en) 2015-10-30
TN2014000256A1 (en) 2015-09-30
SG11201404061YA (en) 2014-08-28
SI2804863T1 (sl) 2016-05-31
TW201335161A (zh) 2013-09-01
ZA201404314B (en) 2015-08-26
CO7000775A2 (es) 2014-07-21
IL233541B (en) 2018-12-31
HK1198536A1 (en) 2015-05-15
HUE026984T2 (en) 2016-08-29
ES2564143T8 (es) 2020-11-18
EP2804863A1 (en) 2014-11-26
PH12014501638A1 (en) 2014-10-13
UY34576A (es) 2013-09-02
BR112014017260A8 (pt) 2017-07-04
JP2015503627A (ja) 2015-02-02
KR20140093726A (ko) 2014-07-28
JP5749410B2 (ja) 2015-07-15
TWI609869B (zh) 2018-01-01
PE20142358A1 (es) 2015-01-30
US20160176883A1 (en) 2016-06-23
CA2863339C (en) 2021-03-23
GT201400155A (es) 2017-09-28
BR112014017260A2 (pt) 2017-06-13
MA35858B1 (fr) 2014-12-01
JO3137B1 (ar) 2017-09-20
US9334276B2 (en) 2016-05-10
EA026232B1 (ru) 2017-03-31
KR20140141687A (ko) 2014-12-10
CA2863339A1 (en) 2013-07-25
CR20140345A (es) 2014-09-09
AU2013209952A1 (en) 2014-07-24
HRP20160178T1 (hr) 2016-03-25
EP2804863B1 (en) 2015-12-02
MX2014008686A (es) 2014-08-27
AP2014007762A0 (en) 2014-07-31
AR089728A1 (es) 2014-09-10
PL2804863T3 (pl) 2016-06-30
IN2014DN06781A (pl) 2015-05-22
DK2804863T3 (en) 2016-03-07

Similar Documents

Publication Publication Date Title
FR22C1030I2 (fr) Formes cristallines d'un inhibiteur de la prolyle hydroxylase
SMT201600083B (it) Nuove forme e sali di un inibitore di diidropirrolo[1,2-c]imidazolil aldosterone sintasi o aromatasi
SMT201700052B (it) 2-(azaindol-2-il)benzimidazoli come inibitori di pad4
CR20120576A (es) Inhibidores de pirazolil quinazolina cinasa
IL237582A0 (en) Cdk inhibitors
EP2710007A4 (en) Kinase inhibitors
CO6970602A2 (es) Inhibidores de quinasa
SMT201500291B (it) Nuovi agenti antimalarici
HRP20151310T1 (xx) Spojevi piridazinona i njihova uporaba kao inhibitori daao
BR112013025761A2 (pt) inibidores de hsp90
IL224178A (en) Heterogeneous history of cervix as hcv inhibitors
LT3070091T (lt) Benzodioksolo dariniai kaip fosfodiesterazės inhibitoriai
EP2623763A4 (en) Cylinder head
EP2933248A4 (en) NOVEL RENIN INHIBITOR
IL233712A0 (en) Sulfonamide derivatives used as mogat–2 inhibitors
BR112013030341A2 (pt) inibidores de glutaminil ciclase radiomarcados
BR112013014148A2 (pt) inibidores de corrosão
EP2629616A4 (en) SUBSTITUTED AMINO-TRIAZOLYL-PDE10-HEMMER
EP2753623A4 (en) GAMMASEKRETASEHEMMER
EP2694057A4 (en) LIPOXYGENASE INHIBITORS
BR112013010699A2 (pt) derivados de pirrolidina usados como inibidores de catepsina
BR112013014484A2 (pt) compostos inibidores de metaloenzimas
EP2861071A4 (en) ALDOSTERONSYNTHASEHEMMER
IL227814A0 (en) Cathepsin c inhibitors
FI20105909A0 (fi) Suutinpää